In case you missed it: March 15 to March 19
It was a very busy week for the Contemporary OB/GYN team.
This week’s top articles included:
SMFM 2021: Selected Scientific Advances
From the March issue of Contemporary OB/GYN®, this article details the most interesting discoveries presented at the Society for Maternal-Fetal Medicine's 2021 Virtual Annual Pregnancy Meeting. Read the full issue here.
Evolving patient evaluation and therapies for uterine fibroids
When it comes to diagnosing women with uterine fibroids (UFs), no single patient, fibroid or lived experience is the same, according to Sony Sukhbir Singh, MD, a professor of gynecology at the University of Ottawa and The Ottawa Hospital in Ontario, Canada.
NIH Offers Grant Extensions for Grantees Affected by COVID-19
The National Institutes of Health (NIH) announced that it will offer grant extensions to eligible grantees affected by COVID-19.
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
